Cui Ling, Xie Xiao-Yan, Wang He, Chen Xin-Lian, Liu Shan-Ling, Hu Li-Na
Laboratory of Genetics, West China Institute of Women and Children's Health, West China Second Hospital, Sichuan University, Chengdu 610041, China.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Jan;44(1):57-9.
To investigate the long non-coding RNA HOTAIR (long non-coding HOX antisense intergenic RNA) by examining HOTAIR expression levels in ovarian cancer tissue and normal ovarian tissue.
The mRNA of long non-coding RNA HOTAIR expressions were detected by real-time fluorescence quantitative PCR in ovarian cancer (44) and normal ovary tissues (14).
The expression of HOTAIR in ovarian cancer tissue was higher than that in normal ovarian tissue (1.26 +/- 0.27 vs. 0.14 +/- 0.09, P < 0.05). The expression was statistically higher in poorly differentiated ovarian cancer than poorly-moderately, moderately-well, and well-differentiated ones (1.65 +/- 0.41 vs. 0.39 +/- 0.14, P < 0.05).
RNA HOTAIR expressions were higher in ovarian cancer; it may play a role in ovarian cancer, and become a biomarker for malignant degree of ovarian cancer and may provide a novel therapeutic target for ovarian cancer.
通过检测卵巢癌组织和正常卵巢组织中长链非编码RNA HOTAIR(长链非编码HOX反义基因间RNA)的表达水平,对其进行研究。
采用实时荧光定量PCR检测44例卵巢癌组织和14例正常卵巢组织中长链非编码RNA HOTAIR的mRNA表达。
卵巢癌组织中HOTAIR的表达高于正常卵巢组织(1.26±0.27对0.14±0.09,P<0.05)。在低分化卵巢癌中的表达显著高于中低分化、中高分化和高分化卵巢癌(1.65±0.41对0.39±0.14,P<0.05)。
RNA HOTAIR在卵巢癌中表达较高;它可能在卵巢癌中发挥作用,成为卵巢癌恶性程度的生物标志物,并可能为卵巢癌提供新的治疗靶点。